Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Burns

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Blood|August 29, 2015
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLLRomain Guièze, Pauline Robbe, Ruth Clifford, et al.
Blood|December 17, 2013
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damageRuth Clifford, Tania Louis, Pauline Robbe, et al.
Nature Medicine|March 20, 2026
Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areasClara Chamba, Heavenlight Christopher, Emmanuel Josephat, et al.
Nature Genetics|November 5, 2022
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical featuresPauline Robbe, Kate E Ridout, Dimitrios V Vavoulis, et al.
Transfusion|September 29, 2022
The BLOODSAFE program: Building the future of access to safe blood in Sub-Saharan AfricaMeghan Delaney, Susan Telke, Shimian Zou, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Blood|August 29, 2015
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLLRomain Guièze, Pauline Robbe, Ruth Clifford, et al.
Blood|December 17, 2013
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damageRuth Clifford, Tania Louis, Pauline Robbe, et al.
Nature Medicine|March 20, 2026
Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areasClara Chamba, Heavenlight Christopher, Emmanuel Josephat, et al.
Nature Genetics|November 5, 2022
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical featuresPauline Robbe, Kate E Ridout, Dimitrios V Vavoulis, et al.
Transfusion|September 29, 2022
The BLOODSAFE program: Building the future of access to safe blood in Sub-Saharan AfricaMeghan Delaney, Susan Telke, Shimian Zou, et al.
Pageof 3